slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 78,601-78,630
Pages 3,679
Rows per page 30
Component
78,601-78,630 of 110,355
24
Includes footnotes explaining adjustments for non-ordinary course disputes and stock-based compensation.FIGS | Results Presentation Deck | 26 slides · FIGS
Conference presentation Investor relations Beat · Action1 hit
25
Contains two distinct financial reconciliation tables with footnotes.FIGS | Results Presentation Deck | 26 slides · FIGS
Conference presentation Investor relations Beat · Action1 hit
04
Uses an analogy to position the company as a marketplace leader.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations 1 hit
07
The slide uses a process-flow diagram to illustrate the market structure and the low penetration of digital platforms (~2%).Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations Beat · Problem1 hit
08
Uses a map-based diagram to connect specific industry pain points to global trade routes.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
23
The slide explicitly mentions a 'flywheel' model, though it is presented as a data visualization rather than a process diagram.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations Beat · Financial Overview1 hit
32
The table includes a footnote regarding non-recurring share listing expenses.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations 1 hit
34
The table provides a clear breakdown of non-cash and non-recurring items used to adjust the operating loss.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations 1 hit
07
Includes a cytogenetic map showing the 600kb deletion region on chromosome 3.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · NeedLoop · Golden Circle1 hit
13
The slide uses a line chart (Seahorse XF Glycolysis Stress Test profile) and a bar chart to show metabolic impact.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
19
The slide includes a timeline of the study and two line charts showing tumor volume over time for different treatment groups.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
22
Includes a histological image showing negative TUSC2 expression.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
26
Includes bioluminescence imaging and quantitative bar chart with statistical significance markers (p-values).Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
30
The chart shows tumor volume over time (days) for four groups, demonstrating synergistic efficacy of the dual gene therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
37
Includes a scientific diagram illustrating the transition from hyperglycemia (beta-cell deficiency) to euglycemia (restored beta-cell mass) via AAV-mediated gene delivery.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
39
The slide uses a comparative analogy between mouse lifespan and human lifespan to suggest long-term efficacy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
40
The slide uses a combination of a process description (left) and experimental data (line chart and bar chart) to validate the therapeutic hypothesis.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
41
NHP = Non-Human Primate. STZ likely refers to Streptozotocin, a compound used to induce diabetes in animal models.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
43
The data shows a significant improvement in glucose regulation post-therapy, closely tracking the normal NHP curve.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
56
Includes bioluminescence imaging of tumor xenografts and bar charts quantifying Active T cells, MDSC, Active NK cells, and DC populations.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
05
The slide uses a 'why now' framing to justify the market opportunity for a sustainable brand.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations 1 hit
06
The slide uses a background image of ocean plastic pollution to establish emotional context.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Includes a Venn diagram illustrating the intersection of 'Digitally Enabled' and 'Beyond Plastic Brand Leadership'.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
09
The chart uses a trend line to highlight the improvement over five years.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The chart shows a clear downward trend in SG&A expenses over time, with a specific callout for a Q1-2024 restructuring gain.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The slide uses two bar charts to demonstrate customer cohort value expansion over time.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
The slide uses a testimonial to reinforce the strategic shift into new categories.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
26
Includes footnotes for data sources.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
29
The chart uses a visual arrow to emphasize the projected growth trend from Q3 to Q4.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
34
Standard financial reconciliation table showing adjustments for non-cash and non-recurring items.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit